WaveTec Vision announced it has closed a new $16.5 million financing round to commercialize its ORA System diagnostic device for cataract surgery. The latest round was led by new investor Burrill & Co. WaveTec Vision’s previous investors also participated in this round of financing, including Versant Ventures, Accuitive Medical Ventures, De Novo Ventures and Gund Investment Corp. The ORA System uses proprietary Optiwave technology with a precise new light source that enhances the quality of the wavefront image to improve measurement accuracy and ensure better patient outcomes. Privately held WaveTec Vision provides intraoperative wavefront measurement technology for refractive cataract surgeons. For more information, visit: www.wavetecvision.com